Astrazeneca (AZN) Common Equity (2009 - 2026)
Astrazeneca (AZN) reported Common Equity of $50.37 billion for Q2 2026, up 12.4% from $44.81 billion a year earlier and up 6.3% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Astrazeneca posted Common Equity of $48.72 billion, up 19.2% from FY2024.
- Common Equity has increased for three consecutive years, with a five-year compound annual growth rate of 25.5% (FY2020 to FY2025).
- By year, Common Equity came in at $40.87 billion in FY2024 (+4.4%), $39.17 billion in FY2023 (+5.7%), $37.06 billion in FY2022 (-5.7%) and $39.29 billion in FY2021 (+151.2%).
- The Q2 2026 figure ranks as the highest quarterly Common Equity in data going back to Q1 2009.
- Year over year, Common Equity has now increased in each of the last 13 quarters, with growth averaging 12.0% over the last eight quarters.
- The high point for year-over-year Common Equity in five years was Q3 2021 (growth of 193.1%); the low point was Q3 2022 (a decline of 11.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $47.38 billion (Q1 2026), $48.72 billion (Q4 2025) and $45.97 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 22.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.37 Bn |
| Mar 31, 2026 | 47.38 Bn |
| Dec 31, 2025 | 48.72 Bn |
| Sep 30, 2025 | 45.97 Bn |
| Jun 30, 2025 | 44.81 Bn |
| Mar 31, 2025 | 41.13 Bn |
| Dec 31, 2024 | 40.87 Bn |
| Sep 30, 2024 | 40.81 Bn |
| Jun 30, 2024 | 39.60 Bn |
| Mar 31, 2024 | 37.50 Bn |
| Dec 31, 2023 | 39.17 Bn |
| Sep 30, 2023 | 37.22 Bn |
| Jun 30, 2023 | 37.42 Bn |
| Mar 31, 2023 | 35.81 Bn |
| Dec 31, 2022 | 37.06 Bn |
| Sep 30, 2022 | 35.15 Bn |
| Jun 30, 2022 | 35.95 Bn |
| Mar 31, 2022 | 36.36 Bn |
| Dec 31, 2021 | 39.29 Bn |
| Sep 30, 2021 | 39.91 Bn |
API Access
Astrazeneca Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();